BACKGROUND: Depressive disorders have a large impact on psychosocial functioning. Since lower functioning predicts recurrence of a depressive episode, insight into the post-morbid course of psychosocial functioning of persons with different depressive disorders may facilitate recurrence prevention. METHODS: Data were derived from NEMESIS, an epidemiologic survey in the adult population in the Netherlands. Respondents, who met the CIDI criteria of major depression (MDD; n=102), dysthymic disorder (Dysth; n=66) or double depression (DD; n=73) at baseline, and recovered during three year follow-up, were included; as was a control group without any diagnosis (NoDiag, n=4140). Functioning was assessed using the Groningen Social Disability Schedule (GSDS) and the SF-36 physical health summary-scale. Linear Mixed Models were conducted to compare 3-year trajectories of functioning across depressive groups and with NoDiag group. RESULTS: Compared to NoDiag, all depressed groups were significantly impaired on social and physical functioning. Dysth and DD had a lower level of post-morbid physical functioning compared to MDD (after 1 and 3 years respectively: Dysth: B=-13.8, p=.002 and B=-8.11, p=.09; DD: B=-8.9, p=.03 and B=-9.1, p=.05). Determinants for impaired social functioning (neuroticism) and for impaired physical functioning (age, comorbid somatic disorders and neuroticism) were identified. LIMITATIONS: Attrition was higher among persons with a depression. Inclusion of the drop-outs would most likely have resulted in stronger associations, since we expect lower functioning among the drop-outs. CONCLUSION: This study indicates the long-term debilitating effects of psychopathology, even after recovery of depressive disorders. Duration of the index symptoms appears to be associated with impaired functioning, since especially those with Dysthymia (either with or without a MDD) showed slower and less recovery of functioning.
BACKGROUND:Depressive disorders have a large impact on psychosocial functioning. Since lower functioning predicts recurrence of a depressive episode, insight into the post-morbid course of psychosocial functioning of persons with different depressive disorders may facilitate recurrence prevention. METHODS: Data were derived from NEMESIS, an epidemiologic survey in the adult population in the Netherlands. Respondents, who met the CIDI criteria of major depression (MDD; n=102), dysthymic disorder (Dysth; n=66) or double depression (DD; n=73) at baseline, and recovered during three year follow-up, were included; as was a control group without any diagnosis (NoDiag, n=4140). Functioning was assessed using the Groningen Social Disability Schedule (GSDS) and the SF-36 physical health summary-scale. Linear Mixed Models were conducted to compare 3-year trajectories of functioning across depressive groups and with NoDiag group. RESULTS: Compared to NoDiag, all depressed groups were significantly impaired on social and physical functioning. Dysth and DD had a lower level of post-morbid physical functioning compared to MDD (after 1 and 3 years respectively: Dysth: B=-13.8, p=.002 and B=-8.11, p=.09; DD: B=-8.9, p=.03 and B=-9.1, p=.05). Determinants for impaired social functioning (neuroticism) and for impaired physical functioning (age, comorbid somatic disorders and neuroticism) were identified. LIMITATIONS: Attrition was higher among persons with a depression. Inclusion of the drop-outs would most likely have resulted in stronger associations, since we expect lower functioning among the drop-outs. CONCLUSION: This study indicates the long-term debilitating effects of psychopathology, even after recovery of depressive disorders. Duration of the index symptoms appears to be associated with impaired functioning, since especially those with Dysthymia (either with or without a MDD) showed slower and less recovery of functioning.
Authors: Robert T Ammerman; Frank W Putnam; Mekibib Altaye; Angelique R Teeters; Jack Stevens; Judith B Van Ginkel Journal: Child Abuse Negl Date: 2013-04-25
Authors: Adina S Fischer; Bailey Holt-Gosselin; Scott L Fleming; Laura M Hack; Tali M Ball; Alan F Schatzberg; Leanne M Williams Journal: Neuropsychopharmacology Date: 2020-11-23 Impact factor: 7.853
Authors: Yu-Chen Chiang; Tsan-Hon Liou; Hsin-Chien Lee; Reuben Escorpizo Journal: Int J Environ Res Public Health Date: 2021-04-25 Impact factor: 3.390
Authors: María Cabello; Francisco Félix Caballero; Somnath Chatterji; Alarcos Cieza; José Luis Ayuso-Mateos Journal: Health Qual Life Outcomes Date: 2014-12-17 Impact factor: 3.186
Authors: Heidi Taipale; Johan Reutfors; Antti Tanskanen; Lena Brandt; Jari Tiihonen; Allitia DiBernardo; Ellenor Mittendorfer-Rutz; Philip Brenner Journal: BMC Psychiatry Date: 2020-05-13 Impact factor: 3.630
Authors: Rose M Collard; Sanne Wassink-Vossen; Aart H Schene; Paul Naarding; Peter Verhaak; Richard C Oude Voshaar; Hannie C Comijs Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-06-19 Impact factor: 4.328